PL3303369T3 - Chimeryczna cząstka wirusowa wirusa x ziemniaka i jej zastosowanie do diagnozy in vitro zespołu sjögrena - Google Patents
Chimeryczna cząstka wirusowa wirusa x ziemniaka i jej zastosowanie do diagnozy in vitro zespołu sjögrenaInfo
- Publication number
- PL3303369T3 PL3303369T3 PL16747629T PL16747629T PL3303369T3 PL 3303369 T3 PL3303369 T3 PL 3303369T3 PL 16747629 T PL16747629 T PL 16747629T PL 16747629 T PL16747629 T PL 16747629T PL 3303369 T3 PL3303369 T3 PL 3303369T3
- Authority
- PL
- Poland
- Prior art keywords
- potato virus
- vitro diagnosis
- sjögren syndrome
- chimeric particle
- viral chimeric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/40011—Tymoviridae
- C12N2770/40022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB20151199 | 2015-06-03 | ||
| PCT/IT2016/000146 WO2016194014A1 (en) | 2015-06-03 | 2016-06-03 | Viral chimeric particle of potato virus x and use thereof for in vitro diagnosis of sjögren syndrome |
| EP16747629.0A EP3303369B1 (en) | 2015-06-03 | 2016-06-03 | Viral chimeric particle of potato virus x and use thereof for in vitro diagnosis of sjögren syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3303369T3 true PL3303369T3 (pl) | 2020-03-31 |
Family
ID=54288887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16747629T PL3303369T3 (pl) | 2015-06-03 | 2016-06-03 | Chimeryczna cząstka wirusowa wirusa x ziemniaka i jej zastosowanie do diagnozy in vitro zespołu sjögrena |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10626149B2 (pl) |
| EP (1) | EP3303369B1 (pl) |
| CA (1) | CA2988072A1 (pl) |
| ES (1) | ES2753170T3 (pl) |
| PL (1) | PL3303369T3 (pl) |
| WO (1) | WO2016194014A1 (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9522940B2 (en) * | 2012-05-23 | 2016-12-20 | Pieris Pharmaceuticals Gmbh | Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3 |
-
2016
- 2016-06-03 EP EP16747629.0A patent/EP3303369B1/en active Active
- 2016-06-03 PL PL16747629T patent/PL3303369T3/pl unknown
- 2016-06-03 ES ES16747629T patent/ES2753170T3/es active Active
- 2016-06-03 WO PCT/IT2016/000146 patent/WO2016194014A1/en not_active Ceased
- 2016-06-03 CA CA2988072A patent/CA2988072A1/en not_active Abandoned
- 2016-06-03 US US15/579,150 patent/US10626149B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016194014A1 (en) | 2016-12-08 |
| EP3303369B1 (en) | 2019-08-07 |
| US20180170970A1 (en) | 2018-06-21 |
| US10626149B2 (en) | 2020-04-21 |
| ES2753170T3 (es) | 2020-04-07 |
| EP3303369A1 (en) | 2018-04-11 |
| CA2988072A1 (en) | 2016-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202007323VA (en) | Hepatitis b virus (hbv) irna compositions and methods of use thereof | |
| IL258326B (en) | Antibodies that neutralize the hepatitis b virus in potency and their uses | |
| IL251450A0 (en) | Preparations and methods for silencing hepatitis b virus gene expression | |
| SG11201606819QA (en) | Compositions for the inactivation of virus replication and methods of making and using the same | |
| EP3318465A4 (en) | Baby wagon with improved ease of use | |
| IL236838A0 (en) | Antibodies against dengue virus and uses thereof | |
| IL286265A (en) | A new tilapia virus and its uses | |
| IL244431A0 (en) | Pharmacy methods and preparations for the treatment of hepatitis b virus infection | |
| SG11201606624WA (en) | Antibody moleules to dengue virus and uses thereof | |
| ZA201701643B (en) | Pyrrolopyrimidines for use in influenza virus infection | |
| ZA201701909B (en) | Trichoderma compositions and methods of use | |
| IL249660B (en) | Methods for treating hepatitis b virus and hepatitis d virus infections | |
| GB2526430B (en) | Joint mechanism and child high chair thereof | |
| SG11201701669PA (en) | Flavivirus virus like particle | |
| EP3025730A4 (en) | Viral immunotherapy drug complex and uses thereof | |
| IL258682B (en) | Viral neoepitopes and their uses | |
| PL2969005T3 (pl) | Atenuowane wirusy grypy i szczepionki | |
| SG11201703366RA (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
| IL246643A0 (en) | Preparations and kits for the treatment of immunodeficiency virus/acquired immunodeficiency syndrome | |
| PL2948157T3 (pl) | Zastosowanie genetycznie zmodyfikowanego zakaźnego wirusa odry o wzmocnionych właściwościach proapoptotycznych (wirusa MV-deltaC) w terapii nowotworów | |
| EP2968394A4 (en) | NEW VACCINES AGAINST MULTIPLE SUBTYPES OF THE DENGUE VIRUS | |
| GB201400760D0 (en) | Use of geneticaly modified virus in order to remove viral latency shown on HIV example | |
| GB201403086D0 (en) | Selection of virus and agent useful in the treatment of cancer | |
| AU2014904252A0 (en) | All-in-one Nappy Bag and Change Mat |